| Country Head of ERC, Japan |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
12月 06, 2024 |
| Associate Director, SpeakUp Office EMEA |
Prague |
Czech Republic |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
12月 06, 2024 |
| Associate Director, Risk & Assurance |
New Cairo |
Egypt |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
12月 03, 2024 |
| Senior IP Counsel |
East Hanover |
USA |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
12月 03, 2024 |
| Senior IP Counsel / Litigation Counsel |
Basel (City) |
Switzerland |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
12月 03, 2024 |
| Head Quality Operations, Legal |
East Hanover |
USA |
Legal |
CTS |
Legal & Intellectual Property & Compl. |
12月 03, 2024 |
| Vodja procesov upravljanj tveganj in odpornosti (m/ž/d) / Risk & Resilience Lead, Operations (m/f/d) |
Ljubljana |
Slovenia |
Ethics Risk & Compliance |
CTS |
Legal & Intellectual Property & Compl. |
11月 26, 2024 |
| Associate Director, Labor Rights EMEA |
Prague |
Czech Republic |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
11月 22, 2024 |
| Associate Director Risk, Policy & Controls |
Dublin (NOCC) |
Ireland |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
11月 18, 2024 |
| Head Legal APMA |
Mapletree Business City (MBC) |
Singapore |
Legal |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
11月 14, 2024 |
| Functional Lead, Compliance Analytics and Reporting |
Telangana |
India |
Operations |
CTS |
Legal & Intellectual Property & Compl. |
9月 18, 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
8月 22, 2024 |
| Patent Paralegal |
Cambridge (USA) |
USA |
Legal |
Pharma Research |
Legal & Intellectual Property & Compl. |
7月 19, 2024 |